Search results
Results from the WOW.Com Content Network
Lokivetmab, trade name Cytopoint, is a monoclonal antibody used to treat atopic dermatitis in dogs. [1] It acts against interleukin 31 (IL-31), [2] which is a cytokine involved in causing itchiness (pruritus). [2] Lokivetmab is administered by subcutaneous injection; each dose is effective for four to eight weeks. [3]
Description - includes the proprietary name (if any), nonproprietary name, dosage form(s), qualitative and/or quantitative ingredient information, the pharmacologic or therapeutic class of the drug, chemical name and structural formula of the drug, and if appropriate, other important chemical or physical information, such as physical constants ...
When used as drugs, the International Nonproprietary Names (INNs) end in -mab. The remaining syllables of the INNs, as well as the column Source, are explained in Nomenclature of monoclonal antibodies. Types of monoclonal antibodies with other structures than naturally occurring antibodies.
If the template has a separate documentation page (usually called "Template:template name/doc"), add [[Category:Drug templates by ATC]] to the <includeonly> section at the bottom of that page. Otherwise, add <noinclude>[[Category:Drug templates by ATC]]</noinclude>
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
[[Category:Drug templates by structure]] to the <includeonly> section at the bottom of that page. Otherwise, add <noinclude>[[Category:Drug templates by structure]]</noinclude> to the end of the template code, making sure it starts on the same line as the code's last character.
[[Category:Drug templates]] to the <includeonly> section at the bottom of that page. Otherwise, add <noinclude>[[Category:Drug templates]]</noinclude> to the end of the template code, making sure it starts on the same line as the code's last character.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Donate